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IT WaS shownby Little et al. (I933) andKorteweg (I933) thatthesusceptibility
to cancer of the mammary glands of mice is partly determined by a non-genetic
extrachromosomal influence. That this influence is transferred from mother to
young by means of the milk was later proved by Bittner (1936). Korteweg
(1936a, b) predicted that chromosomal factors must also be active. Thispredic-
tion was based onthe factthat differences insusceptibility to cancerexistbetween
dba females and theFl hybridsofthe dba x C57 black cross. Thepresent paper
concems these chromosomal factors.
The fact that chromosomal factors exist is important, but the way they act,
their mechanism, is of still greater inter'est. A number of investigators have
considered the role of the follicular hormone, and checked the possibility of
differences between the oestrus cycles of the high-cancer and low-cancer strains
ofmice. As no differences were found this form ofexperiment was discontinued.
Yet I was not convinced. I spayed females of different strains, and after-
wards determined the sensitivity ofthe vaginalepithelium to oestrone by means
of the vaginal smear method. I found-that, to cause oestrus, it was necessary to
inject three times as much oestrone into females ofthe high-cancer strain dba as
in those of the low-cancer C57 black. As the course of natural oestrus in both
these strains is the same, I concluded that normaldba femalesproduce threetimes
as much oestrone as normal C57 females. I suggested (Korteweg, 1935) that
this overproduction of oestrone in dba females might enhance their susceptibihty to cancer. Since these results were published in 1935 this li-ne of research has
been continued with the aid of my co-workers, van Gulik aiid Miihlbock, up to
the present time, interrupted only by war circumstances.
Our low-cancer strain 020 also proved to be very sensitive to oestrone,, as
judgedby the oestrus test inspayedfemales, The females ofthis straintherefore
probably produce onlyrelatively little ofthis hormone (van Gulik andKorteweg, 1940). In accord with this result, Shimkin and Andervont. (1941) found their
low-cancer strain C57 black much more sensitive than their high-cancer strain
C314. On purely anatomical grounds Fekete (1946) concluded that dba mice
produce more oestrone than C57 females. I can confirm her findings. The
ovaries of our high-cancer strain greatly sur ass those of our low-cancer ammals
in volume. This is partly caused by the somewhat greater num'ber of graafian follicles,partly by the much greater number of corpora lutea, and partly by the92 R. kORTgWEG
existence oflarge follicularcysts in dba mice. According to NathansonofBoston
(personal communication) the ovaries of the highcancer strain CM closely
resemble those ofthe dba strain.
Since in the repiprocal Fl hybrids between dba and C57 the sensitivity to
oestrone was the same and about intermediate between the sensitivity in the
parent strains, we concluded that these differences'in sensitivity to oestrone had
nothing to do with the milk factor (van Gulik and Korteweg, 1940). Shimkin
and Andervont (1941), by means offosternursing experiments, reachedth.-same
conclusion.'
At the present time we know from the experiments on oestrus response to
injected oestrone in spayed females that in mice of two high-cancer strains more
oestrone is being produced than in those of two low-cancer strains, but from this
we may not yet conclude that the production of a larger quantity of oestrone is
a quahty of mice of all high-cancer strains. This remains to be seen, and the
-present communication is therefore only of a preliminary character.
Here adigression is necessary. The generalopinion seems to be that whereas
in the human after puberty there are both oestrogenic and luteal ovarianphases,
there is in unmated mice no luteal change (Pullinger, 1947). This surely is not
true. Hooker (1945) recorded that the effect of progesterone can be demon-
strated in'the structure of.the endometrial stroma just as well as the effect of
oestrone. I have found that the epithelium of the uterus of the virginal mouse
also shows a response to progesterone. As in the endometrium of the human
female, in which on the 17th day of the cycle, shortly after the bursti'ng of the
follicle when theluteinizing process is beginning, a vacuole becomes visible in the
basal pait of the epithelial cells, so also this phenomenon occurs in the virginal
mouse. It is the'refore necessary to be aware always of the possibility- that
progesterone too may influence susceptibility to cancer (by its synergistic'action
withoestrone).
If the mammary glands'also of high-cancer strain mice should be relatively
insensitive to oestrone, as is thevaginalepithelium ofhigh-cancer strain animals,
thenthe excess ofoestroneproduced wouldprobably be harmless to the mammary
glands. If, on the contrary, the sensitivity of the mammary glands of high-
and low-cancer strain animals should be the same, the excess of oestrone pro-
duced in high-cancer strainanimals might be injurious to the mammary glands.
It therefore became necessary to determine the'sensitivity to oestrone of the
mammary glands. As the result ofinjecting a total of 108 LU. of oestrone into
21-months-oldspayed females of different str'ains, it seemed evident to van Gulik
and myself that our high-cancer strain females dba reacted to a lesser degree to
oestronethan ourlow-cancer strainanimals whenjudgedby the extent ofdevelop-
ment of the glands. In 21-m'onths-old castrated males injected with 13 I.U. of
oestrone, we found more growth also in the low-cancer than in the high-cancer
strains. Miihlbock then drew our attention to the fact that in our experiments
we had injected large doses. If one wishes to determine the sensitivit'y of an
organ it is preferable to determine the threshold dose'. As the first visible sign
of an effect of oestrone, Miihlbock (1948a) took the beginning of budding of the
end of the milk ducts (swelling of the end bulbs). He injected non-castrated
5-months-old males of our three strains with different doses of oestrone. Again
more oestrone was needed in the high-cancer than in the low-cancer strain
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All previous experiments seemed to prove that in high-cancer strain animals
the mammary glands are relatively less sensitive to oestrone than are those of
low-cancer strain mice (Korteweg, 1947). Nevertheless, when determining the
threshold dose of oestrone in spayed 6 weeks-old females Muihlbock (1948b) found
by this test that the mammary glands of high-cancer strain females are just as
sensitive as those oflow-cancer strain mice. Males ofthe same strains have also
been examined by Miihlbock (1948a). Two facts appeared. Firstly in the males
of the three strains C57 black, dba and 020, the sensitivity of the mammary
gland is about the same according to the threshold test. Secondly, the minimal
dose causing budding (swelling of end bulbs) in castrated males is approximately
five times less than in non-castrated males. Obviously in non-castrated males
the testosterone largely counteracts the oestrone. This supposition proved to be
right, as in castrated males which were injected both with oestrone and testo-
sterone, the presence of the latter suppressed the action of the former. In non-
castrated males three times as much oestrone is needed to cause budding (swelling
of end bulbs) in the glands of high-cancer strain dba mice than in those of low-
cancer strain mice; in castrated males the sensitivity is the same. The only
possible conclusion to be drawn from these facts seems to be that in the high-
cancer strain males which were examined, the quantity of testosterone produced
exceeds that of the low-cancer strain males by three times. This relatively high
production of oestrone in females and oftestosterone in males of our high-cancer
strain suggests that at the bottom of this phenomenon there exists a relatively
high production of gonadotrophic hormone in this strain. This gives a hint
that from now on our attention should be fixed especially on the hypophysis.
SUMMARY.
It was found by the oestrus test in spayed females that our high-cancer strain
animals produce relatively large amounts of oestrone in comparison with low-
cancer strain mice. This excess of oestrone acts on a mammary gland which is
just as sensitive to the action ofthis hormone as is the gland oflow-canceranimals
when sensitivity is judged by the threshold response at 6 weeks old. That
means that the mammary glands of our high-cancer strain females are exposed
to abnormal stimulation by oestrone. It therefore seems probable that at least
part of the genetically determined disposition to mammary cancer in certain
strains of mice is caused by an overproduction of this hormone.
Ifin the A strain, with its great difference in cancer incidence between virgins
and breeders, the production of oestrone should prove to be low, then the differ-
ences in production demonstrated by us might be identified with the so-called
"inherited hormonal influence " referred to in the literature. If, on the con-
trary, the production of oestrone in the A strain should prove to be high, and if
the same should be the case in the other high-cancer strains, then these differences
ofoestrone production will have to be identified with another, not yet determined
genetic factor.
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SINcE Bittner (1940) first postulated that at least three factors, namely, the
milk factor, the hormonal factor, and the genetic factor or genetic constitution,
play a part in the origin of breast cancer in inbred strains ofmice, in a number of
laboratories a great amount of work has been carried out on each of the factors.
The interaction of all three factors in the development of breast cancer in mice
has been clearly shown (Bittner, 1945) and the influence of other factors like
abnormal environmental and metabolic conditions has been described (Morris,
1945).
Experiments showing the interaction of mammary tumour inducing or milk
factor and genetic constitution in the development of breast tumours in certain
high- andlow-breast cancer strains of mice willbe described in the present paper,
and the importance of the genetic factors shown.
Experiment No. 1.
Susceptibility to the milk factor begins to decrease gradually after birth,
and susceptible mice after they reach maturity are quite resistant to the action
of the milk factor (Bittner, 1942a; Andervont, Shimkin and Bryan, 1942.)
Following these observations, an experiment was carried out to find out
whether it would be possible by administering sufficient quantities of milk factor
in tumour tissue from RIII and Strong A high-breast-cancer strains to induce
breast cancerinsusceptible C57 x Strong A hybridfemaleswhich hadnot obtained
the factor while suckling and were 16 weeks old. Litter mates of these mice,
4-6 weeks old, were used as controls. The two age-groups of C57 x Strong A
hybrid females, each were subdivided into two groups according to the number of
subcutaneous injections of distilled water suspensions of dried RIII or Strong A
breast tumour tissue. Mice in each separate group were given equal quantities